Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest The Scripps Research Institute Stories

2013-09-09 16:23:57

HOUSTON, Sept. 9, 2013 /PRNewswire-USNewswire/ -- Dr. Huda Zoghbi (http://www.bcm.edu/genetics/index.cfm?pmid=11053), a ground-breaking geneticist at Baylor College of Medicine (www.bcm.edu) and the Jan and Dan Duncan Neurological Research Institute (www.nri.texaschildrens.org) at Texas Children's Hospital, will receive the 2013 Pearl Meister Greengard Prize (http://greengardprize.rockefeller.edu) from The Rockefeller University in a ceremony on Dec. 5. The prize, established by...

2013-09-09 16:23:29

Celebrating 10 Years of Honoring the Achievements of Women in Science NEW YORK, Sept. 9, 2013 /PRNewswire-USNewswire/ -- The Rockefeller University announced today that Huda Y. Zoghbi, M.D., will receive the 10(th) annual Pearl Meister Greengard Prize--one of the world's preeminent honors recognizing outstanding achievements by women in science. Dr. Zoghbi was chosen by a selection committee of ten members, including five Nobel laureates and two recipients of the Breakthrough Prize...

2013-08-21 12:25:14

Hao Li recognized for his work on algorithms that can model both tumors and facial motion LOS ANGELES, Aug. 21, 2013 /PRNewswire-USNewswire/ -- Today MIT Technology Review reveals its Innovators Under 35 list. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the world. For his work in the field of software, USC Viterbi School of Engineering's Hao Li has been honored as an outstanding...

2013-07-31 08:30:47

HUNTSVILLE, Ala., July 31, 2013 /PRNewswire/ -- Serina Therapeutics, Inc., a pharmaceutical research and development company that has developed a proprietary, patented polymer technology for drug development, announced today that the company has entered into a research agreement with the Scripps Research Institute for development of polymer-antibody drug conjugates (Polymer-ADCs). The nature of the agreement and the financial terms were not disclosed. "Antibody drug conjugates...

False Memories Implanted In Mice
2013-07-26 05:15:40

redOrbit Staff & Wire Reports - Your Universe Online Researchers exploring the phenomenon of false memory have taken a page out of science fiction, successfully demonstrating that fake recollections could be implanted into the brains of mice. The study, which appears in Thursday's edition of the journal Science, might sound like something out of a Philip K. Dick short story or a Leonardo DiCaprio movie, but it has serious real-world implications, especially in the criminal justice...

2013-07-18 08:29:01

Agreement marks first partnership of its kind between a research institution and reagents company; third major deal in TSRI's new partnering strategy SAINT LOUIS and LA JOLLA, Calif., July 18, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced a partnership with The Scripps Research Institute (TSRI) to fund research and provide immediate, day-of-publication access to TSRI researchers' discoveries for the synthesis and analysis of potential drugs. The...

2013-07-17 23:04:31

New members from PwC, The Scripps Research Institute, Latham & Watkins and Thermo Fisher Scientific strengthen current board La Jolla, Calif. (PRWEB) July 17, 2013 California Healthcare Institute (CHI) announced today the election of four senior executives to serve on its board of directors: Peter Claude, partner at PwC US; Dr. Michael Marletta, president and CEO of The Scripps Research Institute (TSRI); Alan Mendelson, partner at Latham & Watkins; and Dr. Marc Tremblay,...

2013-07-15 13:33:43

An international group of scientists has shown that a drug candidate designed by scientists from the Florida campus of The Scripps Research Institute (TSRI) significantly increases exercise endurance in animal models. These findings could lead to new approaches to helping people with conditions that acutely limit exercise tolerance, such as obesity, chronic obstructive pulmonary disease (COPD) and congestive heart failure, as well as the decline of muscle capacity associated with aging....

2013-07-09 08:28:27

Program Highlights Include CEO Panel on the Affordable Care Act, with Expert Progress Reports on Personalized Medicine, Neurodegenerative Disease and Oncology Research NEW YORK, July 9, 2013 /PRNewswire/ -- The Galien Foundation today announced the formal program of presenters and panels for its Fourth Galien Forum, scheduled for Tuesday, October 22, 2013 at the Alexandria Life Sciences Center in New York City. The Galien Forum, conducted in conjunction with the prestigious Prix...

2013-07-01 08:27:02

- ChromaDex's Niagen(TM) is the First and Only Commercially Available Nicotinamide Riboside - IRVINE, Calif., July 1, 2013 /PRNewswire/ -- ChromaDex Corp.(®) (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with The Scripps Research...